Goldman Sachs’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.5K Sell
21,390
-14,425
-40% -$46.5K ﹤0.01% 6291
2025
Q4
$110K Buy
+35,815
New +$123K ﹤0.01% 6173
2025
Q3
Sell
-10,054
Closed -$42.2K 6409
2025
Q2
$42.2K Sell
10,054
-1,814
-15% -$7.11K ﹤0.01% 5932
2025
Q1
$39.6K Sell
11,868
-49,250
-81% -$201K ﹤0.01% 5905
2024
Q4
$254K Buy
61,118
+3,977
+7% +$16.7K ﹤0.01% 5552
2024
Q3
$209K Sell
57,141
-7,715
-12% -$30.6K ﹤0.01% 5442
2024
Q2
$311K Buy
+64,856
New +$364K ﹤0.01% 5089

Other funds holding EVO

Goldman Sachs's EVO Position: Q1 2026 in Review

Goldman Sachs reduced its Evotec (EVO) stake by 40% in Q1 2026, selling an estimated $46.5K and leaving 21,390 shares worth $53.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6291.

Goldman Sachs first reported a position in EVO in Q2 2024 and has held it in 7 quarters since. The position peaked at $311K in Q2 2024. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

  • Goldman Sachs held 21,390 shares of Evotec worth $53.5K as of Q1 2026.
  • Goldman Sachs sold 14,425 Evotec shares in Q1 2026, an estimated $46.5K.
  • Evotec made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6291 holding.
  • Goldman Sachs first reported a position in Evotec in Q2 2024 and has held it in 7 quarters since.
  • Goldman Sachs's Evotec position peaked at $311K in Q2 2024.
  • 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.